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Abstract 
 
Advanced glycation endproducts (AGEs) have been implicated in the pathogenesis of 
cancer, inflammatory conditions and diabetic complications. An interaction of AGEs 
with their receptor (RAGE) results in increased release of pro-inflammatory cytokines 
and reactive oxygen species (ROS), causing damage to susceptible tissues. Laminitis, 
a debilitating foot condition of horses, occurs in association with endocrine 
dysfunction and the potential involvement of AGE and RAGE in the pathogenesis of 
the disease has not been previously investigated. Glucose transport in lamellar tissue 
is thought to be largely insulin-independent (GLUT-1), which may make the lamellae 
susceptible to protein glycosylation and oxidative stress during periods of increased 
glucose metabolism. Archived lamellar tissue from horses with insulin-induced 
laminitis (n = 4), normal control horses (n = 4) and horses in the developmental stages 
(6 h, 12 h and 24 h) of the disease (n = 12) was assessed for AGE accumulation and 
the presence of oxidative protein damage and cellular lipid peroxidation. The equine-
specific RAGE gene was identified in lamellar tissue, sequenced and is now available 
on GenBank. Lamellar glucose transporter (GLUT-1 and GLUT-4) gene expression 
was assessed quantitatively with qRT-PCR in laminitic and control horses and horses 
in the mid-developmental time-point (24 h) of the disease. Significant AGE 
accumulation had occurred by the onset of insulin-induced laminitis (48 h) but not at 
earlier time-points, or in control horses. Evidence of oxidative stress was not found in 
any group. The equine-specific RAGE gene was not expressed differently in treated 
and control animals, nor was the insulin-dependent glucose transporter GLUT-4. 
However, the glucose transporter GLUT-1 was increased in lamellar tissue in the 
developmental stages of insulin-induced laminitis compared to control horses and the 
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insulin-independent nature of the lamellae may facilitate AGE formation. However, 
due to the lack of AGE accumulation during disease development and a failure to 
detect an increase in ROS or upregulation of RAGE, it appears unlikely that oxidative 
stress and protein glycosylation play a central role in the pathogenesis of acute, 
insulin-induced laminitis. 
 
Keywords: Equine; Glucose; AGE; RAGE; GLUT-1; Oxidative stress 
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1. Introduction 
 
The study of protein glycosylation and the formation of advanced glycation 
endproducts (AGEs) has become an increasingly important area of research since 
recognition of their role in the progression of diabetic complications (Brownlee, 
1992a). AGEs are formed by an irreversible non-enzymatic reaction (the Maillard 
reaction) between carbohydrates and proteins (or lipids or nucleic acids) containing a 
free amino group (Singh et al., 2001). AGEs accumulate in tissues as a consequence 
of aging and during several pathological processes that include hyperglycaemia, 
cancer and inflammation (Brownlee, 1992b; Ramasamy et al., 2005; Takino et al., 
2010). The concentration of AGEs in a tissue depends, in part, on the availability of 
carbohydrate (usually glucose) and thus glycation is enhanced in diabetic patients 
(Yamagishi and Matsui, 2010). However, AGEs can form during euglycaemia, 
especially in cells that are freely permeable to glucose (Schmidt et al., 1995).  
 
AGEs are capable of modulating cell function by binding with multiple cell surface 
binding sites, of which the best characterised is the signal transduction receptor 
known as RAGE (Bucciarelli et al., 2002). An interaction between AGE and RAGE 
results in the release of pro-inflammatory cytokines and oxidative stress, thrombosis 
and over-expression of various proteins in the extra-cellular matrix (ECM) such as 
collagen and laminin (Brownlee, 1992a; Gawlowski et al., 2009; Sick et al., 2010; 
Simm et al., 2004). In diabetic humans, basement membrane pathology results in 
renal, vascular and retinal complications that increase morbidity and mortality rates 
associated with the disease (Giugliano et al., 1996; Yamagishi and Matsui, 2010, 
2011). 
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While hyperglycaemia is seldom reported in horses and the development of diabetes 
mellitus is rare (Johnson et al., 2005), insulin resistance seems to be increasingly 
common (Geor and Frank, 2009). One complication of altered insulin and glucose 
metabolism in horses and ponies is the development of laminitis, a foot disease that 
can result in lameness and loss of function (Jeffcott et al., 1986; Johnson et al., 2004). 
The pathogenesis of endocrinopathic laminitis is only partially understood and 
potential mechanisms for the disease include vascular perturbations to the digit, ECM 
degradation, glucotoxicity, inflammation and oxidative stress (de Laat et al., 2010b; 
Geor and Frank, 2009).  
 
Although laminitis occurring in conjunction with hyperinsulinaemia has received 
attention, less is known about hyperglycaemia and abnormal glucose metabolism in 
this species. Hoof lamellar tissue contains both insulin-dependent (GLUT-4) and 
insulin-independent (GLUT-1) glucose transporters (Asplin et al., 2011; Mobasheri et 
al., 2004). Strong mRNA expression of GLUT-1 was present in the lamellae of ponies 
with insulin-induced laminitis and normal controls (Asplin et al., 2011), which may 
indicate that overexposure of lamellar cells to glucose is feasible, even during 
euglycaemia.  
 
Clinical and histopathological laminitis has been induced experimentally in horses 
and ponies with a euglycaemic, hyperinsulinaemic clamp (Asplin et al., 2007; de Laat 
et al., 2010a), permitting study of the developmental and acute stages of 
hyperinsulinaemic laminitis. Other experimentally-induced and naturally-occurring 
forms of laminitis have been linked with excessive production of pro-inflammatory 
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cytokines, supporting a role for inflammation in the disease pathogenesis (Belknap et 
al., 2007; Treiber et al., 2009). Reactive oxygen species (ROS) can be released from 
damaged inflammatory cells during disease states such as diabetes, and cause tissue 
damage (Siekmeier et al., 2007). However, whether pro-inflammatory cytokines and 
oxidative stress play a significant role in endocrinopathic laminitis pathophysiology is 
unclear. To our knowledge, determination of whether AGEs accumulate in the 
lamellar tissue of horses with hyperinsulinaemia has not yet been investigated. ROS 
have been studied previously in horses, but not in those with experimentally-induced 
hyperinsulinaemic laminitis. Analysis of AGEs and ROS concentrations in lamellar 
tissue from horses in the developmental phase of insulin-induced laminitis will 
determine whether these inflammatory processes occur prior to the onset of clinical 
signs at 48 h, thus investigating their role in disease pathogenesis.  
 
The study hypothesis was that advanced glycation and oxidative stress are increased 
in the developmental and acute stages of insulin-induced laminitis and contribute to 
disease pathogenesis.  The aims of the current study were to quantify lamellar glucose 
transporter (GLUT-1 and GLUT-4) gene expression, and determine if protein 
glycosylation and oxidative lipid and protein damage occur in lamellar tissue, during 
the developmental (6 h, 12 h, 24 h) and acute (48 h) stages of insulin-induced 
laminitis, and compare this to normal horses. Identification of the equine-specific 
RAGE gene has not, to our knowledge, been previously reported in horses. RAGE is 
present on many cell types including endothelial cells, keratinocytes and monocytes 
(Brett et al., 1993; Lohwasser et al., 2005), and these cells are present in equine 
lamellae (Faleiros et al., 2011).  A secondary aim of the study was to confirm the 
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presence of the equine-specific RAGE gene in lamellar tissue and submit the 
sequence to GenBank. 
 
2. Materials and Methods 
 
2.1. Samples 
 
The experimental protocol was approved by the Animal Ethics Committee of The 
University of Queensland which ensured compliance with the Animal Welfare Act of 
Queensland (2001) and the Australian Code of Practice for the Care and Use of 
Animals for Scientific Purposes (7th edition 2004). Archived hoof lamellar tissue 
from Standardbred horses treated with a euglycaemic hyperinsulinaemic clamp (n = 
16), or a balanced electrolyte solution (n = 4), was used in the current study (de Laat 
et al., 2010a; de Laat et al., 2011). Horses in the treatment group received a combined 
insulin (Humulin-R (Eli Lily, Australia), 6 mIU/kg bwt/min) and glucose (50% 
dextrose (Baxter, Australia), variable rate to maintain euglycaemia) i.v. infusion for 6 
h (n = 4), 12 h (n = 4), 24 h (n = 4), or until the onset of Obel grade 2 (Obel, 1948) 
laminitis (48 h; n = 4). Control horses were treated for 48 h. Age, bodyweight and 
body condition score was similar for each group of horses (Table 1). Blood samples 
(10 mL) were taken from the left jugular vein during the experiment to measure blood 
glucose (mmol/L) and serum insulin (µIU/mL) concentration (Table 1). Blood 
glucose was measured immediately with a glucometer (Accucheck-Go, Roche, 
Switzerland) validated for equine blood (ρc = 0.96) and serum was stored at -80°C 
until analysed for insulin concentration with a validated (McGowan et al., 2008) 
radioimmunoassay (Coat-a-count, Siemens Healthcare Diagnostics, IL, U.S.A.). 
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Samples of lamellar tissue from all horses were examined for markers of oxidative 
damage, whereas only the 24 h, 48 h and control groups were analysed for RAGE, 
GLUT-1 and GLUT-4 gene expression.  
 
2.2. Oxidative protein damage and lipid peroxidation 
 
Protein was extracted from 100 mg of frozen hoof lamellar tissue by homogenisation 
as described previously (de Laat et al., 2011). Total protein concentration was assayed 
in triplicate (intra-assay CV = 4.1%) using the bicinchoninic acid method (Pierce, IL, 
USA) and measured on a NanoDrop (Thermo Scientific, DE, U.S.A.) 
spectrophotometer (562 nm). Protein samples from each horse were diluted (1 x 
phosphate buffered saline) to a final concentration of 10 µg/mL and contained a 
detergent (Triton X-100) concentration of < 0.001% to prevent interference with the 
protein coating of the ELISA plate.  
 
Commercial ELISA kits (Oxiselect, Cell Biolabs, CA, and U.S.A.) were used 
according to the manufacturer’s instructions for the detection and quantification of 
AGE- and malondialdehyde (MDA)-protein adducts and protein carbonyls, against 
known bovine serum albumin (BSA) conjugated standards, in all samples. 
Commercial ELISAs have been used previously to measure ROS in horses 
(McFarlane and Cribb, 2005; Treiber et al., 2009). Although an AGE-adduct ELISA 
has not been used previously in horses to our knowledge, AGE structure is consistent 
regardless of the protein source and the antibody kits are thus suitable for use with 
any species (Cell Biolabs, CA, U.S.A.). Absorbance was measured on a microplate 
reader (Titertek Multiskan Plus MKII, Titertek-Berthold, AL, U.S.A.) at 450 nm. 
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2.3. RNA extraction and cDNA synthesis 
 
Frozen lamellar tissue (100 mg) was pulverised in a pre-chilled heavy-duty foil 
envelope on a cold metal block and total RNA was extracted using 1mL of Trizol 
reagent (Invitrogen, Australia) according to the manufacturer’s instructions. Each 
sample was visualised on a 2% agarose gel with SybrSafe stain (Invitrogen, Australia) 
to confirm RNA integrity, and RNA concentration was determined by UV 
spectrophotometry. Prior to cDNA synthesis, RNA samples were treated with RNAse-
free DNAse I (Invitrogen, Australia) to eliminate possible genomic DNA 
contamination. For each sample, 1µg of total RNA was reverse-transcribed to cDNA 
using the Reverse Transcription System (Promega, WI, U.S.A.) and stored at -80°C 
until analysis. 
 
2.4. Cloning and sequencing of the equine-specific RAGE gene  
 
Oligonucleotide primer sets for the RAGE gene were designed within the most 
homologous region based on multiple alignments of the bovine, murine and human 
sequences and synthesized by Sigma Aldrich, Australia. PCR products of the 
predicted size (409 bp) were cloned into the pGEM-T easy cloning vector (Promega, 
WI, U.S.A.) and positive colonies were sequenced using an M13 universal sequencing 
primer and a Big Dye Terminator Cycle Sequencing Kit 3.1 (ABI Prism, Applied 
Biosystems, Australia). The nucleotide sequence was resolved on an automated DNA 
sequencer (Applied Biosystems 373A). Programs from the Australian National 
Genomic Information Services (ANGIS) were used to analyse the resulting DNA 
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sequences. The equine-specific RAGE gene sequence is now available on GenBank; 
accession number: BankIt1492591JQ004799. 
 
2.5. qRT-PCR and PCR analyses 
 
The qRT-PCR assays for relative quantification of GLUT-1, GLUT-4, and RAGE in 
lamellar tissue samples were performed using SensiMix 2 x SYBR Green Master Mix 
(Bioline, Australia).  The PCR primer sets for each target gene and for two house-
keeping genes (Table 2) were designed from equine-specific sequences (GenBank 
accession no: GLUT-1, DQ139875, GLUT-4, AF531753, β2-microglobulin, X69083 
and GAPDH, AF157626) using primer design software (Primer3 v 0.4.0, 
http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) and synthesized by Sigma 
Aldrich, Australia. Two different house-keeping genes have been used to investigate 
other forms of laminitis (Coyne et al., 2009; Visser, 2008) so both were analysed in 
the current study in order to select the most stable house-keeping gene. Analysis of 
the amplification efficiency (E = 10[–1/slope]) of the target and house-keeping genes was 
determined on serial dilutions of cDNA by qRT-PCR, with each primer set having 
efficiencies within 10% of 2, which permits use of the 2-∆CT equation (Schmittgen and 
Livak, 2008). The specificity of all primers used in this study was checked via a Blast 
search (Altschul et al., 1997) and the results were confirmed by detection of a single 
band of the expected PCR product size following 2% agarose gel electrophoresis (data 
not shown).  
 
PCR reactions were set-up in 100-well genediscs (Qiagen, Australia) using a Corbett 
CAS-1200 robot (Qiagen, Australia) and run on a Corbett Rotor-Gene 6000 series 
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(Qiagen, Australia).  The exact primer concentrations and PCR conditions were 
determined during initial optimisation runs.  Following optimisation experiments, 
assays of 10 µL reaction volumes were prepared comprising 2 µL optimally diluted 
cDNA, 5 µL of SensiMix 2 x SYBR Green Master Mix (Bioline, Australia), 1 µL H20 
and 2 µL of forward and reverse primers at varying concentrations as determined by 
optimisation experiments (Table 2). The cycling conditions were as follows: 95°C for 
10 min, followed by 45 cycles of 15 s at 95°C, 15 s at 58 °C and 30 s at 72°C.  
Specificity of the amplified products was checked immediately after the PCR with 
melting curve analysis and sequencing of the PCR products.  All samples were 
amplified on the same disc for every primer pair to ensure equal amplification 
conditions. No-template controls using water instead of cDNA templates were 
included for each gene as negative controls. Samples were amplified in duplicate and 
the results recorded as cycle threshold (CT) values of background-subtracted, qPCR 
fluorescence kinetics.  For each sample, CT values for each target gene were averaged 
and relative gene expression was calculated for target genes against the reference gene 
β2-microglobulin, using the 2-∆CT method (Schmittgen and Livak, 2008). 
 
2.6. Statistical analyses 
 
Serum insulin, blood glucose, AGE and ROS concentrations and gene expression 
were compared between groups using Kruskal-Wallis ANOVA on ranks. Pair-wise 
comparisons were made with Tukey’s post-hoc test. All data are expressed as mean ± 
se or median (range) and significance was accepted at p < 0.05. Statistical analyses 
were performed using R, version 7.2.7. 
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3. Results 
 
3.1. Oxidative protein damage and lipid peroxidation 
 
The concentration of AGEs (ng/mL) in the lamellae of control horses and in treated 
horses during the developmental phases of laminitis (6 h, 12 h, 24 h) was negligible. 
A significant accumulation of AGEs had occurred by the acute phase (48 h) of 
laminitis (Table 3). Lamellar concentration of the lipid peroxidation product MDA 
(pmol/mg) did not differ between groups (Table 3). However, the lamellar protein 
carbonyl (nmol/mg) tissue concentration was decreased (p < 0.05) late in the 
developmental phase (24 h) of laminitis compared to the other time-points (Table 3). 
 
3.2. Gene expression 
 
As expected, the equine-specific RAGE gene sequence showed very high homology 
(86 – 89%) to all identified species due to the highly conserved nature of the region 
used to design the primers. β2-microglobulin was determined to be the most stable 
house-keeping gene. Both GLUT-1 and GLUT-4 were found to be present in lamellar 
tissue (Table 4). Relative gene expression of GLUT-1 was increased in the group 
treated with insulin for 24 h compared to the control group whereas GLUT-4 and 
RAGE gene expression did not differ between the groups (Table 4).  
 
4. Discussion  
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The accumulation of AGEs in the lamellar tissue of horses after just 48 h of 
hyperinsulinaemia is a significant finding of this study. To our knowledge, this is the 
first study to examine the concentration of protein glycosylation by-products in 
equine hoof lamellae. The finding of negligible amounts of AGEs in normal lamellae 
is not surprising given the young age of the horses studied, and shows that AGEs do 
not appear to be routinely present in the lamellae of young horses. Recent evidence 
has shown that AGEs can be generated more rapidly than previously thought and are 
potential early arrivals at sites of injury and trauma (Ramasamy et al., 2005). This 
premise is supported in the current study by the finding of significant AGE 
accumulation in the lamellae of horses with Obel grade 2 (Obel, 1948) lameness 
following 48 h of hyperinsulinaemia. The AGE concentrations in lamellar tissue, in 
this acute stage of laminitis, were modest and further accumulation of AGEs may 
have occurred if the study had been prolonged.  
 
AGE generation leads to increased release of ROS and inflammation, which initiates 
an ongoing cycle of AGE accumulation and oxidative stress (Ramasamy et al., 2010). 
The failure to detect an increase in oxidative protein damage (protein carbonyl) and 
cellular lipid peroxidation (MDA) as a consequence of the insulin and glucose 
infusion in this study may be due to the acute time-course of the experiment. However, 
a lack of oxidative stress has also been reported in more chronic forms of 
endocrinopathic laminitis (Keen et al., 2004; Treiber et al., 2009). Neither oxidants 
(MDA, 3-nitrotyrosine) nor anti-oxidants (glutathione, glutathione peroxidase and 
superoxide dismutase) were found to be increased in blood samples from ponies that 
had previously suffered recurrent, pasture-associated laminitis when compared to 
ponies that had never experienced laminitis (Treiber et al., 2009). Likewise, studies on 
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ponies with equine Cushing’s disease, which is a condition consistently associated 
with an increased risk for laminitis (McGowan et al., 2004), found no difference in 
MDA and glutathione peroxidase levels in peripheral blood samples between affected 
and normal animals (Keen et al., 2004).  
 
Other experimental models of laminitis (alimentary and inflammatory) also have not 
been associated with increased lamellar lipid peroxidation or protein carbonylation 
(Burns et al., 2011). However, researchers have found that the equine digital lamellae 
may be particularly susceptible to injury induced by ROS, due to a lack of the anti-
oxidant, superoxide dismutase (Loftus et al., 2007). Further studies have demonstrated 
that the addition of superoxide dismutase blocks AGE production in cultured bovine 
endothelial cells exposed to hyperglycaemia (Nishikawa et al., 2000). Anti-oxidant 
markers were not examined in this study and analysis of their potential role in the 
suppression of oxidative stress in insulin-induced laminitis is warranted. 
 
The identification and sequencing of the equine-specific RAGE gene in the lamellar 
tissue of horses is a novel finding of this study. The lack of RAGE upregulation in the 
current study may be a consequence of the euglycaemic status of the subjects or 
alternatively, may simply be related to the acute time-course of the study. Increased 
expression of an enzyme that degrades AGEs, glyoxalase 1, has been shown to 
prevent increases in RAGE expression and reduce ROS production (Yao and 
Brownlee, 2010), and if present in the horses in the current study may have 
contributed to the lack of upregulation of RAGE and ROS. Analysis of glyoxalase 1 
would be required to further investigate this. 
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Three previous studies using different techniques agree that the insulin-independent 
glucose transporter, GLUT-1, is expressed in the lamellae of healthy horses and 
ponies (Asplin et al., 2011; Mobasheri et al., 2004; Wattle and Pollitt, 2004). While 
Mobasheri et al. (2004) reported that immunolocalisation of insulin-dependent 
GLUT-4 was strong in normal lamellar keratinocytes, the opposite was found by 
Wattle and Pollitt (2004). GLUT-4 lamellar mRNA expression was also not found to 
be prevalent in healthy horses and ponies using conventional PCR (Asplin et al., 
2011). Quantitative RT-PCR results from the current study showed that both GLUT-1 
and GLUT-4 were present in the lamellar tissue of control horses.  
 
Conventional PCR has shown that lamellar GLUT-1 mRNA expression was strong in 
ponies with insulin-induced laminitis and equine Cushing’s disease, while GLUT-4 
expression was weak (Asplin et al., 2011). In chronic laminitis, lamellar 
immunolocalisation of GLUT-1 and GLUT-4 was decreased (Mobasheri et al., 2004). 
In the current study, gene expression of GLUT-4 remained unchanged between 
groups, whereas GLUT-1 was upregulated in the lamellar tissue of horses treated for 
24 h. Failure of GLUT-1 expression to remain significantly elevated at the onset of 
laminitis (48 h) may suggest that GLUT-1 expression decreased as the disease 
progressed, similar to the findings of Mobasheri et al. (2004). Alternatively, the small 
samples sizes may account for an apparent increase in GLUT-1 expression at 48 h not 
reaching statistical significance. A reliance on GLUT-1 facilitative glucose transport 
may suggest that glucose saturation of lamellar keratinocytes can occur during 
increased glucose delivery. The upregulation of lamellar GLUT-1 gene expression in 
the developmental stages of insulin-induced laminitis may further predispose this 
tissue to glucose saturation. Lamellar AGE accumulation in the horses treated with 
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insulin and glucose for 48 h may be enabled by the largely insulin-independent nature 
of glucose transport in this tissue. 
 
In human diabetic patients, AGEs result in the over-production of laminin and 
collagen, causing thickening and reduced elasticity of the ECM, which can lead to 
complications such as nephropathy (Dronavalli et al., 2008; Mendez et al., 2010). 
This occurs by a receptor-independent pathway (Wendt et al., 2003). Widening of the 
basement membrane has been reported following ultrastructural analysis of insulin-
induced laminitis in two ponies (n = 5) and AGEs may contribute to this ECM 
pathology (Nourian et al., 2009). However, studies of alimentary carbohydrate 
overload laminitis have reported a loss of structural components of the ECM (collagen 
type IV and laminin-5) in the developmental and acute (48 h) phase of the disease 
(Visser and Pollitt, 2011), which suggests that different pathogenic mechanisms may 
occur in hyperinsulinaemic laminitis. Temporal analysis of ECM components in 
insulin-induced laminitis is required.  
 
However, while AGE accumulation occurred in the treated horses concurrently with 
the development of major lamellar pathology, such as ECM dysfunction, some 
lamellar pathological processes, including morphological changes and cellular 
proliferation, have been observed earlier (12 h to 24 h) in the developmental phase (de 
Laat et al., unpublished data). Thus, histopathological changes precede the onset of 
clinical disease and AGE accumulation (24 to 48 h). Furthermore, RAGE 
upregulation did not occur during the development or onset of laminitis. Thus, it is 
unlikely that AGE-RAGE interaction plays a significant role in the pathogenesis of 
acute hyperinsulinaemic laminitis. However, AGEs may contribute to lamellar 
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pathology by receptor-independent pathways. AGE involvement in chronic forms of 
the disease is also possible, as further generation of AGEs may occur as the disease 
progresses. Lamellar AGE concentration in chronic disease requires investigation. 
 
In the present study, advanced glycation of lamellar tissue occurred within 48 h in 
horses treated with insulin and glucose. Although protein glycosylation may 
contribute to lamellar ECM pathology, and potentially complicate the disease in the 
longer term, it appears unlikely to be the sole aetiopathogenic factor in 
hyperinsulinaemic laminitis. Based on the current results, further investigations of 
AGEs, RAGE and the role of ROS in lamellar disease in horses are warranted. 
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Tables 
Table 1: Mean ± se age, bodyweight, body condition score (BCS) and median (range) 
serum insulin (µIU/mL) and blood glucose (mmol/L) concentration for five groups of 
Standardbred horses treated with either a glucose and insulin infusion for 6 h (n = 4), 
12 h (n = 4), 24 h (n = 4), 48 h (n = 4) or with an electrolyte solution for 48 h (n = 4).  
Parameters Control 6 h 12 h 24 h 48 h 
Age (years) 5.4 ± 0.6 9.0 ± 2.0 5.8 ± 1.8 7.3 ± 2.2 5.8 ± 1.3 
Bodyweight (kg) 432 ± 14 428 ± 18 463 ± 40 429 ± 16 427 ± 34 
BCS (1 – 9) 4.3 ± 0.25 4.5 ± 0.6 5 ± 0.4 4.5 ± 0.3 4.6 ± 0.25 
Serum Insulin 
(µIU/mL) 
9.4 (8.7 - 
11.5) * 
884 (498 - 
1165) 
1093 (883 - 
1269) 
918 (852 - 
1123) 
1080 (1028 - 
1201) 
Blood Glucose 
(mmol/L) 
5.8 (5.4 - 6.4) 4.1 (3.5 - 
4.3) 
3.8 (3.5 - 4.4) 5.0 (4.0 - 
5.9) 
4.6 (4.0 - 5.6) 
Key: * p < 0.05 compared with all other groups (Tukey’s test) 
 
Table 2: Primer sequences and concentrations (nM) for quantitative Real Time- 
Polymerase Chain Reaction (qRT-PCR) gene expression of the receptor for advanced 
glycation endproducts (RAGE) and glucose transporters (GLUT-1 and GLUT-4) in 
lamellar tissue from normal horses (n = 4) and horses in the developmental (24 h; n = 
4) and acute (48 h; n = 4) stages of insulin-induced laminitis. 
Gene Forward primer (5'-3') 
Reverse primer 
(5'-3') 
Amplicon size 
(bp) 
Primer 
conc. (nM) 
β2- 
Microglobulin 
 
ACCCAGCAGAGAATGGAAAGC 
 
CATCTTCTCTCCATTCTTTAGCAAATC 101 600 
GAPDH GAT TGT CAG CAA TGC CTC CT AAG CAG GGA TGA TGT TCT GG 193 500 
 27 
RAGE TTC TGA CTT GCT CCC ACT TTG TT 
GTC TGC TTC TCT CTG ACC TTA TCC 
A 90 600 
GLUT-1 CTTTGGCCGGCGGAAT AAGGACTTGCCCAGTTTTGAGA 91 500 
GLUT-4 TGCTATGGGTCCCTACGTCTTC GAAACCCGAGGCCGGA 95 500 
 
 
Table 3: Lamellar concentration of AGEs, MDA, and protein carbonyl (median, range) 
in five groups of Standardbred horses treated with either a glucose and insulin 
infusion for 6 h (n = 4), 12 h (n = 4), 24 h (n = 4), 48 h (n = 4) or with an electrolyte 
solution for 48 h (n = 4).  
Parameters Control 6 h 12 h 24 h 48 h 
AGE (ng/mL) 1 (0.6 - 8.5) 
4 (2.4 - 
6.3) 
4 (2.4 – 5.7) 2 (1.6 – 2.7) 
596 (178 – 
1020) * 
MDA (pmol/mg) 
0.31 (0.02 - 
0.6) 
0.07 (0 - 
0.6) 
0.15 (0.06 - 
0.3) 
0.56 (0.3 - 
0.8) 
0.9 (0.5 - 1) 
Protein carbonyl 
(nmol/mg) 
1.9 (1.4 - 2.3) 
2.4 (2.1 - 
3.6) 
1.8 (1.3 - 
3.6) 
0.2 (0.01 - 
0.3) * 
1.5 (1.3 - 1.6) 
Key: * p < 0.05 compared with all other groups (Tukey’s test)  
 
Table 4: GLUT-1, GLUT-4 and RAGE gene expression was analysed by qRT-PCR in 
horses treated with insulin and glucose for 24 h (n = 4), 48 h (n = 4) and control (n = 
4) horses treated with an electrolyte solution. Median (range) relative gene expression 
of target genes to the reference gene β2-Microglobulin (2-∆CT) is shown.  
Subjects GLUT-1 GLUT-4 RAGE 
Control 1.02 (0.47 – 1.40) 5.32 (0.68 – 13.5) 0.05 (0.003 – 0.19) 
Insulin 24h 6.92 (3.09 – 15.3)* 0.8 (0.58 - 6.06) 0.004 (0.0007 – 0.16) 
Insulin 48h 3.65 (2.65 – 9.15) 4.39 (2.32 – 6.35) 0.01 (0.005 – 0.02) 
Key: * Increased (p > 0.05) expression of the GLUT-1 gene compared to the other groups. 
